Chuikyo Rep Interview 1 - JPA Vice President Warns against Rushed Dabate on Yakkasa, 2% Buffer Zone

Masahira Mori, Vice President, Japan Pharmaceutical Association Discussions on the FY2024 drug pricing reform are moving forward. The Central Social Insurance Medical Council’s (Chuikyo) drug pricing subcommittee has already run through overall reform topics and held two hearings with industry...read more